JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
QUICK SEARCH:   [advanced]


     

J Am Coll Cardiol, 1999; 34:343-347
© 1999 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Guarnieri, T.
Right arrow Articles by Lowry, D. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guarnieri, T.
Right arrow Articles by Lowry, D. R.

Intravenous amiodarone for the prevention of atrial fibrillation after open heart surgery: the amiodarone reduction in coronary heart (ARCH) trial

Thomas Guarnieri, MD, FACCa, Shellee Nolan, MD, FACCa, Sidney O. Gottlieb, MD, FACCa, Audrey Dudek, RN, MSNa and David R. Lowry, DrPHa

a St. Joseph Medical Center, Baltimore, Maryland, USA. Intravenous amiodarone was provided by Wyeth-Ayerst



View larger version (22K):

[in a new window]
  		Figure 1 Displayed is the freedom-from-atrial fibrillation in the days after open heart surgery. Both populations have complete follow-up to 30 days. (Solid diamond = placebo group; open square = amiodarone group.)

 




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 1999 by the American College of Cardiology Foundation.